Document:

Exhibit 10.9 

      INDEPENDENT CONTRACTOR AGREEMENT

      

      

      THIS AGREEMENT is made as of the 16th day of August, 2021

      

      

      BETWEEN:

      

      

      FLORA GROWTH CORP., a body corporate duly incorporated under the laws of the Province of Ontario, with an address of
        Suite 900, 65 Queen St. W., Toronto, Ontario M5H2M5

      

      

      (hereinafter called the “Company”)

       

      

                                    OF THE
        FIRST PART

      AND:

      

      

      DYNAMIC CONSULTING OF FLORIDA LLC, a Florida limited
          liability company with an address of [REDACTED].

      

      

      (hereinafter called the “Consultant”)

      

      

              OF THE SECOND PART

      

      

      FOR VALUABLE CONSIDERATION it is hereby agreed as follows:

       

      

      1. The Consultant shall provide consulting services to the Company in his capacity as VP US Legal and Business Affairs of the
        Company. The Consultant shall serve the Company (and/or such subsidiary or subsidiaries of the company as the Company may from time to time require) in such consulting capacity or capacities as may from time to time be determined by management of
        the Company, acting reasonably, and shall perform such duties and exercise such powers as may from time to time be determined by management of the Company, as an independent contractor.

      

      

      2. The term of this Agreement shall commence on August 30, 2021 (the “Effective Date”) and
        shall continue until terminated in accordance with the termination provisions herein (the “Term”).

      

      

      3. The base fee payable to the Consultant for the services performed hereunder shall be US$225,000 per year, plus any applicable
        goods and services taxes, payable in equal monthly amounts in advance on the first business day of each calendar month during the Term. On the Effective Date, the Company shall pay the Consultant a one-time signing bonus in the amount of
        US$20,000.  In addition, each calendar year during the Term, the Consultant will be eligible to receive a discretionary performance-based bonus (with a target bonus of 30% of the Consultant’s annual base fees). The Consultant’s payout for the first
        calendar year ending after the date hereof, if any, shall be prorated based on the date of this Agreement. The actual amount of the Consultant’s bonus will be determined by the board of directors (the “Board”)

        of the Company and will take into consideration the Consultant’s performance as well as the Company’s overall financial performance. If, as at the payout date, (i) this Agreement has terminated, or (ii) the Consultant is under notice of
        termination, the Consultant will not be entitled to any bonus for the performance period or any period thereafter.

      

      

      4. The Consultant shall be granted stock options of the Company to acquire common shares in the capital of the Company (the “Options”) as follows:

      

      

      
        1

        
          

      

      

      

      
        	
                (a)

              	
                On the earlier of (i) the date on which the Company either (x) amends the Company’s 2019 stock option plan (the “Plan”) to increase the number of shares available for
                  the issuance of options thereunder or (y) implements a new equity plan permitting for the issuance of the Options granted hereunder and (ii) February 26, 2022 (the earlier of such date being referred to as the “First Tranche Grant Date”); 50,000 Options to acquire 50,000 common shares in the capital of the Company which shall vest in two equal installments of 25,000 shares on each of the First Tranche Grant Date and on the three
                  month anniversary thereof;

                 

                

              

      

      
        	
                (b)

              	
                on the twelve-month anniversary of the Effective Date; 30,000 Options to acquire 30,000 common shares in the capital of the Company which shall vest in two equal installments of 15,000 shares on each of the
                  date of the grant and on the three-month anniversary thereof;

                 

                

              

      

      
        	
                (c)

              	
                if at any time after the First Tranche Grant Date, the closing share price of the Company’s common shares on the NASDAQ Market shall, for a period of three (3) consecutive trading days, be lower
                  than the closing share price on the Effective Date by an amount equal to or greater than twenty percent (20%), then on the third such day, the Company shall grant to the Consultant, 25,000 Options to acquire 25,000 common shares in the
                  capital of the Company which shall be fully vested on the date of the grant; and

                 

                

              

      

      
        	
                (d)

              	
                if at any time after the First Tranche Grant Date, the closing share price of the Company’s common shares on the NASDAQ Market shall, for a period of three (3) consecutive trading days, be lower
                  than the closing share price on the Effective Date by an amount equal to or greater than forty percent (40%), then on the third such day, the Company shall grant to the Consultant, 25,000 Options to acquire 25,000 common shares in the
                  capital of the Company which shall be fully vested on the date of the grant.

              

      

      

      

      The Options will be issued in accordance with the Company’s Plan (as may be amended) or any new equity plan and the rules of the NASDAQ Capital Markets, will have an exercise price per Option equal to the closing
        price of the common shares on the grant date and will expire five years from the date that the Options are granted. The common shares issued pursuant to the exercise of Options will be subject to a one month hold period from the date of the grant
        of Options. The Consultant shall also be entitled to grants of stock options as the Board may from time to time determine, commensurate with the Consultant’s position, and in accordance with the Plan (as may be amended) or any new equity plan and
        all applicable stock exchange and regulatory approvals.

      

      

      5. The Consultant shall be responsible for:

       

      

      
        	
                a.

              	
                the payment of income taxes and goods and services tax remittances as shall be required by any governmental entity with respect to fees paid by the Company to the Consultant;

                 

                

              

      

      
        	
                b.

              	
                maintaining proper financial records of the Consultant, which records will detail, amongst other things, expenses incurred on behalf of the Company; and

                 

                

              

      

      
        	
                c.

              	
                obtaining all necessary licenses and permits and for complying with all applicable federal, provincial and municipal laws, codes and regulations in connection with the provision of
                  services hereunder, including (but not limited to), the Corruption of Foreign Public Officials Act (Canada), the United States Foreign Corrupt Practice Act, the UK Bribery ACT 2010, and other similar anti-corruption legislation in other
                  jurisdictions to the extent applicable to, and binding on, the services provided by the Consultant, and the Consultant shall, when requested, provide the Company with adequate evidence of compliance with this paragraph.

              

      

      

      

      6. The terms “subsidiary” and “subsidiaries” as used herein mean any corporation or company of which more than 50% of the outstanding
        shares carrying voting rights at all times (provided that the ownership of such shares confers the right at all times to elect at least a majority of the board of directors of such corporation or company) are for the time being owned by or held for
        the Company and/or any other corporation or company in like relation to the Company and include any corporation or company in like relation to a subsidiary.

      
        2

        
          

      

      

      

      7. During the Term, the Consultant shall provide the consulting services to the Company, and the Consultant shall be available to
        provide such services to the Company in a timely manner subject to availability at the time of the request.

      

      

      8. The Consultant shall be reimbursed for all traveling and other expenses actually and properly incurred in connection with the
        duties hereunder.  For all such expenses the Consultant shall furnish to the Company an itemized invoice, detailing the services performed and expenses incurred, including receipts for such expenses on a monthly basis, and the Company will
        reimburse the Consultant within fourteen (14) days of receipt of the Consultant’s invoice for all appropriate invoiced expenses.

      

      

      9. The Consultant shall not, either during the continuance of this Agreement or at any time thereafter, disclose the private affairs
        of the Company, and/or any subsidiary or subsidiaries, or any secrets of the Company and/or any subsidiary or subsidiaries, to any person other than the directors, officers and employees of the Company or for the Company’s purposes and shall not
        (either during the continuance of this Agreement or at any time thereafter) use, for the Consultant’s own purposes or for any purpose other than those of the Company, any information the Consultant may acquire in relation to the business and
        affairs of the Company and/or its subsidiary or subsidiaries.

      

      

      10. The Company shall own and have the right and license to use, copy, modify and prepare derivative works of any of the Consultant’s
        Work Product (defined herein) generated by the services to be performed by the Consultant pursuant hereto as well as all pre-existing work product provided to the Company during the course of the engagement.

      

      

      “Work Product” shall mean all intellectual property including trade secrets, copyrights, patentable inventions or any other rights in any programming, documentation, technology
        or other work product created in connection with the services to be performed by the Consultant pursuant hereto.

      

      

      11. The Consultant shall well and faithfully serve the Company or any subsidiary as aforesaid during the continuance of this
        Agreement to the best of the Consultant’s ability in a competent and professional manner and use best efforts to promote the interests of the Company.

      

      

      12. This Agreement may be terminated at any time for just cause without notice or payment in lieu of notice and without payment of
        any fees whatsoever either by way of anticipated earnings or damages of any kind by advising the Consultant in writing.  Just cause shall be defined to include, but is not limited to the following:

      

      

      
        	
                a.

              	
                Dishonesty or fraud;

              

      

      
        	
                b.

              	
                Theft;

              

      

      
        	
                c.

              	
                Negligence;

              

      

      
        	
                d.

              	
                Material breach of any term of this Agreement;

              

      

      
        	
                e.

              	
                Breach of fiduciary duties;

              

      

      
        	
                f.

              	
                Being guilty of bribery or attempted bribery; or

              

      

      
        	
                g.

              	
                Gross mismanagement.

              

      

      

      

      In the event this Agreement is terminated for just cause, then at the request of the Board, the Consultant shall forthwith resign any position or office that the Consultant then holds with the
        Company or any subsidiary of the Company.

      
        3

        
          

      

      13. The Company may terminate this Agreement without just cause by making a lump sum payment to the Consultant that is equivalent to
        6-months of base fees payable to the Consultant within thirty (30) days of the termination date. Upon any such termination without just cause, all Options previously granted to the Consultant but not yet vested shall immediately vest and become
        exercisable.  The Consultant shall be entitled to terminate this Agreement without cause by delivering notice in writing to the Company no later than 30 days prior to the date of termination.

      

      

      14. The services to be performed by the Consultant pursuant hereto are personal in character, and neither this Agreement nor any
        rights or benefits arising thereunder are assignable by the Consultant without the previous written consent of the Company.

      

      

      15. The Consultant expressly agrees and represents that the services to be performed by the Consultant pursuant hereto are not in
        contravention of any non-compete or non-solicitation obligations by which the Consultant is bound.

      

      

      16. The Company shall indemnify and hold the Consultant harmless to the fullest extent allowed by the law from and against all
        claims, actions, losses, expenses, costs or damages of every nature and kind whatsoever the Consultant may suffer by reason of the fact that the Consultant is or was a consultant, officer, employee or agent of the Company or any subsidiary of the
        Company, or by reason of any act done or not done by the Consultant in any such capacity or capacities, provided that the Consultant acted in good faith, in a manner reasonably believed to be in or not opposed to the best interest of the Company
        and its subsidiaries. All reasonable expenses and costs incurred by the Consultant (including his reasonable attorneys’ fees, retainers and advances of disbursements) shall be paid by the Company in advance of the final disposition of the relevant
        action, suit or proceeding at the Consultant’s request within 20 days after the receipt by the Company of a statement or statements from the Consultant requesting such advance or advances from time to time.

      

      

      17. It is expressly agreed, represented and understood that the parties hereto have entered into an arms-length independent contract
        for the rendering of consulting services and that the Consultant is not the employee, agent or servant of the Company.  Further, this Agreement shall not be deemed to constitute or create any partnership, joint venture, master-servant,
        employer-employee, principal-agent or any other relationship apart from an independent contractor and contractee relationship.  Payments made to the Consultant hereunder shall be made without deduction at source by the Company for the purpose of
        withholding income tax, unemployment insurance payments or Canada Pension Plan contributions or the like.

      

      

      18. Any notice in writing or permitted to be given to the Consultant hereunder shall be sufficiently given if delivered to the
        Consultant personally or mailed by registered mail, postage prepaid, addressed to the Consultant at the last residential address known to the Secretary of the Company.  Any such notice mailed as aforesaid shall be deemed to have been received by
        the Consultant on the first business day following the date of mailing.  Any notice in writing required or permitted to be given to the Company hereunder shall be given by registered mail, postage prepaid, addressed to the Company at the address
        shown on page 1 hereof.  Any such notice mailed as aforesaid shall be deemed to have been received by the Company on the first business day following the date of the mailing.  Any such address for the giving of notices hereunder may be changed by
        notice in writing given hereunder.

      

      

      
        4

        
          

      

      

      

      19. he provisions of this Agreement shall enure to the benefit of and be binding upon the heirs, executors, administrators and legal
        personal representatives of the Consultant and the successors and assigns of the Company.  For this purpose, the terms “successors” and “assigns” shall include any person, firm or corporation or other entity which at any time, whether by merger,
        purchase or otherwise, shall acquire all or substantially all of the assets or business of the Company.

      

      

      20. The division of this Agreement into paragraphs is for the convenience of reference only and shall not affect the construction or
        interpretation of this Agreement.  The terms “this Agreement”, “hereof”, “hereunder” and similar expressions refer to this Agreement and not to any particular paragraph or other portion hereof and include any agreement or instrument supplemental or
        ancillary hereto. Unless something in the subject matter or context is inconsistent therewith, references herein to paragraphs are to paragraphs of this Agreement.

      

      

      21. This Agreement embodies the entire understanding and agreement between the parties with respect to the subject matter hereunder
        and supersedes any prior understandings, negotiations, representations and agreements relating thereto.  No other contract, agreement, representation or warranty between the parties hereto relating to the engagement exists.

      

      

      22. Every provision of this Agreement is intended to be severable.  If any term or provision hereof is determined to be illegal or
        invalid for any reason whatsoever, such illegality or invalidity shall not affect the validity of the remainder of the provisions of this Agreement.

      

      

      23. This Agreement is being delivered and is intended to be performed in the Province of Ontario and shall be construed and enforced
        in accordance with, and the rights of both parties shall be governed by, the laws of such Province and the laws of Canada applicable therein (without regard to conflict of law principles).  For the purpose of all legal proceedings this Agreement
        shall be deemed to have been performed in the Province of Ontario and the courts of the Province of Ontario shall have jurisdiction to entertain any action arising under this Agreement. The Company and the Consultant each hereby attorns to the
        jurisdiction of the courts of the Province of Ontario provided that nothing herein contained shall prevent the Company from proceeding at its election against the Consultant in the courts of any other province or country.

      

      

      24. No amendment to this Agreement shall be valid or binding unless set forth in writing and duly executed by both of the parties
        hereto. No waiver of any breach of any term or provision of this Agreement shall be effective or binding unless made in writing and signed by the party purporting to give the same and, unless otherwise provided in the written waiver, shall be
        limited to the specific breach waived.

      

      

      [signature page follows]

      
        5

        
          

      

      

      

      IN WITNESS WHEREOF this Agreement has been executed as of the day, month and year first above written.

      

      

      

      

      

      

      	 	 	FLORA GROWTH CORP.	 
	 	 	 	 
	 	 	Per: /s/Luis Merchan

            	 
	 	 	Luis Merchan

            	 
	 	 	Authorized Signatory 

            	 
	 	 	 	 
	 	 	 	 
	
              WITNESS

            	 	
              DYNAMIC CONSULTING OF FLORIDA LLC

            	 
	 	 	 	 
	 	 	 	 
	
              /S/ David Mitton

            	 	
              /s/ Matthew Cohen

            	 
	
              Name: David Mitton

            	 	
              Matthew Cohen

              Authorized Person

            	 

      

      

      

      

    

  

  6Exhibit 10.47

         

        

        THESE WARRANTS AND ANY SHARES ACQUIRED UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR
          UNDER ANY APPLICABLE STATE SECURITIES LAWS.  THESE WARRANTS AND SUCH SHARES AND ANY INTEREST OR PARTICIPATION HEREIN OR THEREIN MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION THEREFROM UNDER SUCH ACT AND UNDER
          ANY APPLICABLE STATE SECURITIES LAWS.  THESE WARRANTS AND SUCH SHARES MAY NOT BE EXERCISED OR TRANSFERRED EXCEPT UPON THE CONDITIONS SPECIFIED IN THIS WARRANT CERTIFICATE, AND NO EXERCISE OR TRANSFER OF THESE WARRANTS OR TRANSFER OF SUCH SHARES
          SHALL BE VALID OR EFFECTIVE UNLESS AND UNTIL SUCH CONDITIONS SHALL HAVE BEEN COMPLIED WITH.

        

        

        

        

        FLORA GROWTH CORP.

        

        

        Warrant To Purchase Common Stock

        

        

        Warrant No.: PA-1

        Date of Issuance: May 15, 2021 (“Issuance Date”)

        

        

        Flora Growth Corp., a corporation incorporated in the Province of Ontario (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Boustead Securities, LLC, the registered holder hereof or its permitted assigns (the “Holder”), is
            entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, Company common stock, no par value (“Common Stock”) (including any Warrants to purchase shares issued in exchange, transfer or replacement hereof, the “Warrant”), at any time or
            times on or after the date hereof but not after 11:59 p.m., Eastern Time, on the Expiration Date (as defined below), 398,720 (subject to adjustment as provided
            herein) fully paid and non-assessable shares of Common Stock (the “Warrant Shares”).

        
          	
                  

                  

                	

                

        

        
          	
                  1.

                	
                  EXERCISE OF WARRANT.

                

        

         

          

        (a) Mechanics of Exercise. Subject to the terms and conditions hereof, this Warrant may be exercised by the Holder on any day on or after the date hereof, in whole or in part, by delivery of a written notice
            by electronic mail in the method set forth in Section 7 Notices below in the form attached hereto as Exhibit A (the “Exercise Notice”), of the Holder’s election to
            exercise this Warrant, by submitting information including the then-applicable Exercise Price, number of Warrant Shares purchased equal to or lower than the then-applicable number of Warrant Shares and the FMV (collectively, the “Exercise Information”).  Within one (1) Trading Day following an exercise of this Warrant as aforesaid, the Holder shall deliver payment to the Company of an amount
            equal to the Exercise Price in effect on the date of such exercise multiplied by the number of Warrant Shares as to which this Warrant was so exercised (the “Aggregate Exercise Price”) in cash or via wire
            transfer of immediately available funds if, subject to the provisions of Section 1(c), the Holder has not notified the Company in such Exercise Notice that such exercise is made pursuant to a Cashless Exercise (as defined in Section 1(c)) at a
            time and under circumstances which permit a Cashless Exercise. The Holder shall not be required to deliver the original of this Warrant in order to effect an exercise hereunder. Execution and delivery of an Exercise Notice with respect to less
            than all of the Warrant Shares shall have the same effect as cancellation of the original of this Warrant and issuance of a new Warrant evidencing the right to purchase the remaining number of Warrant Shares. Execution and delivery of an
            Exercise Notice for all of the then-remaining Warrant Shares shall have the same effect as cancellation of the original of this Warrant after delivery of the Warrant Shares in accordance with the terms hereof. On or before the first (1st) Trading Day following the date on which the Company has received an Exercise Notice, upon checking that the Exercise Information supplied by the Holder is
            accurate, the Company shall transmit by email an acknowledgment of confirmation of receipt of such Exercise Notice, in the form attached hereto as Exhibit B, to the Holder and the Company’s
            transfer agent (the “Transfer Agent”). On or before the third (3rd) Trading Day following the date on which the Company has
            received such Exercise Notice and, in the event that the Holder has chosen to exercise in cash,  the receipt of the payment of the Aggregate Exercise Price, the Company shall instruct the Transfer Agent to  issue to the Holder the number of
            Warrant Shares to which the Holder is entitled pursuant to such exercise and to, at the sole direction of the Holder pursuant to the Exercise Notice, hold such Warrant Shares in electronic form at the Transfer Agent registered in the Company’s
            share register in the name of the Holder or its designee (as indicated in the applicable Exercise Notice), or mail to the Holder or, at the Holder’s instruction pursuant to the Exercise Notice, the Holder’s agent or designee, in each case, sent
            by reputable overnight courier to the address as specified in the applicable Exercise Notice, a certificate, registered in the Company’s share register in the name of the Holder or its designee (as indicated in the applicable Exercise Notice).
            Upon delivery of an Exercise Notice  and in the event that the Holder has chosen to exercise in cash, the Company’s receipt of the payment of the Aggregate Exercise Price, the Holder shall be deemed for all corporate purposes to have become the
            holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the certificates evidencing such Warrant Shares (as the case may be). If this Warrant is submitted in
            connection with any exercise pursuant to this Section 1(a) and the total number of Warrant Shares represented by this Warrant is greater than the number of Warrant Shares being acquired by the Holder upon an exercise, then, at the request of
            the Holder, the Company shall as soon as practicable and in no event later than three (3) Business Days after any exercise and at its own expense, issue and deliver to the Holder (or its designee) a new Warrant (in accordance with Section 6(d))
            representing the right to purchase the number of Warrant Shares purchasable immediately prior to such exercise under this Warrant, less the number of Warrant Shares with respect to which this Warrant is exercised. No fractional Warrant Shares
            are to be issued upon the exercise of this Warrant, but rather the number of Warrant Shares to be issued shall be rounded down to the nearest whole number. The Company will from time to time promptly pay all taxes and charges that may be
            imposed upon the Company in respect of the issuance or delivery of Warrant Shares upon the exercise of this Warrant, but the Company shall not be obligated to pay any transfer taxes in respect of this Warrant or such shares.

        

        

        
          1

          
            

        

        

        

        (b) Exercise Price. For purposes of this Warrant, “Exercise Price” means $3.00 per share, subject to adjustment as provided herein.

         

          

        (c) Cashless Exercise. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, exercise this Warrant in whole or in part and, in lieu of making the cash payment
            otherwise contemplated to be made to the Company upon such exercise in payment of the Aggregate Exercise Price, elect instead to receive upon such exercise the “Net Number” of Warrant Shares determined according to the following formula (a “Cashless Exercise”), provided that the Holder may elect to cashless exercise pursuant to this Section  1(c) only if B as set forth in the following formula is higher than C as set forth in the following
            formula:

        

        

        Net Number = (A x B) - (A x C)

        B

        

        

        For purposes of the foregoing formula:

        

        

        A= the total number of shares with respect to which this Warrant is then being exercised.

        

        

        B= the FMV

        

        

        C= the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.

        

        

        (d) Disputes.  In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the number of Warrant Shares to be issued pursuant to the terms hereof, the Company shall promptly
            issue to the Holder the number of Warrant Shares that are not disputed and resolve such dispute in accordance with Section 13.

        

        

        (e) Intentionally Left Blank.

        

        

        (f) Insufficient Authorized Shares. The Company shall at all times keep reserved for issuance under this Warrant a number of shares of Common Stock as shall be necessary to satisfy the Company’s obligation to issue
            Warrant Shares hereunder (without regard to any limitation otherwise contained herein with respect to the number of Warrant Shares that may be acquirable upon exercise of this Warrant). If, notwithstanding the foregoing, and not in limitation
            thereof, at any time while the Warrant remains outstanding the Company does not have a sufficient number of authorized and unreserved shares of Common Stock to satisfy its obligation to reserve for issuance upon exercise of the Warrant at least
            a number of shares of Common Stock equal to the number of shares of Common Stock as shall from time to time be necessary to effect the exercise of the Warrant then outstanding (the “Required Reserve Amount”)
            (an “Authorized Share Failure”), then the Company shall immediately take all action necessary to increase the Company’s authorized shares of Common Stock to an amount sufficient to allow the Company to
            reserve the Required Reserve Amount for the Warrant then outstanding. Without limiting the generality of the foregoing sentence, as soon as practicable after the date of the occurrence of an Authorized Share Failure, but in no event later than
            sixty (60) days after the occurrence of such Authorized Share Failure, the Company shall hold a meeting of its stockholders for the approval of an increase in the number of authorized shares of Common Stock. In connection with such meeting, the
            Company shall provide each stockholder with a proxy statement and shall use its best efforts to solicit its stockholders’ approval of such increase in authorized shares of Common Stock and to cause its board of directors to recommend to the
            stockholders that they approve such proposal.

        

        

        (g) Lockup. The Holder of this Warrant represents that it (or permitted assignees under FINRA Rule 5110(e)(1)) will not sell, transfer, assign, pledge, or hypothecate this Warrant or the securities underlying the
            Warrant, nor will it engage in any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the Warrants or the underlying securities for a period of 180 days from the Issuance Date
            except as provided for in FINRA Rule 5110(e)(2).

        

        

        
          2

          
            

        

        

        

        2. DJUSTMENT OF
              EXERCISE PRICE AND NUMBER OF WARRANT SHARES. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant are subject to adjustment from time to time as set forth in this Section 2.

        

        (a) Stock Dividends and Splits.  If the Company, at any time on or after the date hereof, (i) pays a stock dividend on one or more classes of its then outstanding shares of Common Stock or otherwise makes a
            distribution on any class of capital stock that is payable in shares of Common Stock, (ii) subdivides (by any stock split, stock dividend, recapitalization or otherwise) one or more classes of its then outstanding shares of Common Stock into a
            larger number of shares or (iii) combines (by combination, reverse stock split or otherwise) one or more classes of its then outstanding shares of Common Stock into a smaller number of shares, then in each such case the Exercise Price shall be
            multiplied by a fraction of which the numerator shall be the number of shares of Common Stock outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after
            such event.  Any adjustment made pursuant to clause (i) of this paragraph shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution, and any adjustment
            pursuant to clause (ii) or (iii) of this paragraph shall become effective immediately after the effective date of such subdivision or combination. If any event requiring an adjustment under this paragraph occurs during the period that an
            Exercise Price is calculated hereunder, then the calculation of such Exercise Price shall be adjusted appropriately to reflect such event.

         

          

        (b)      Intentionally Left Blank.

         

        

        (c) Number of Warrant Shares. Simultaneously with any adjustment to the Exercise Price pursuant to only paragraph (a) of this Section 2, the number of Warrant Shares that may be purchased upon exercise of this
            Warrant shall be increased or decreased proportionately, so that after such adjustment the aggregate Exercise Price payable hereunder for the adjusted number of Warrant Shares shall be the same as the aggregate Exercise Price in effect
            immediately prior to such adjustment (without regard to any limitations on exercise contained herein).

         

          

        (d) Other Events. In the event that the Company (or any subsidiary) shall take any action to which the provisions hereof are not strictly applicable, or, if applicable, would not operate to protect the Holder
            from dilution or if any event occurs of the type contemplated by the provisions of this Section 2 but not expressly provided for by such provisions (including, without limitation, the granting of stock appreciation rights, phantom stock rights
            or other rights with equity features), then the Company’s board of directors shall in good faith determine and implement an appropriate adjustment in the Exercise Price and the number of Warrant Shares (if applicable) so as to protect the
            rights of the Holder, provided that no such adjustment pursuant to this Section 2(d) will increase the Exercise Price or decrease the number of Warrant Shares as otherwise determined pursuant to this Section 2, provided further that if the
            Holder does not accept such adjustments as appropriately protecting its interests hereunder against such dilution, then the Company’s board of directors and the Holder shall agree, in good faith, upon an independent investment bank of
            nationally recognized standing to make such appropriate adjustments, whose determination shall be final and binding and whose fees and expenses shall be borne by the Company.

        

        

        
          3

          
            

        

        

        

        (e) Calculations. All calculations under this Section 2 shall be made by rounding to the nearest cent or the nearest 1/100th of
            a share, as applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by or for the account of the Company, and the disposition of any such shares shall be considered an issue or sale
            of Common Stock.

        

        

        3. RIGHTS UPON DISTRIBUTION OF ASSETS. In addition to any adjustments pursuant to Section 2 above, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets)
            to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate
            rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate
            in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon a complete exercise of this Warrant (without regard to any limitations on
            exercise hereof) immediately before the date on which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such
            Distribution.

        

        

        4. NONCIRCUMVENTION. The Company hereby covenants and agrees that the Company will not, by amendment of its certificate of incorporation, bylaws or through any reorganization, transfer of assets, consolidation, merger,
            scheme of arrangement, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all times in good faith carry out all the
            provisions of this Warrant and take all action as may be required to protect the rights of the Holder. Without limiting the generality of the foregoing, the Company (a) shall not increase the par value of the Common Stock receivable upon the
            exercise of this Warrant above the Exercise Price then in effect, (b) shall take all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable shares of Common Stock
            upon the exercise of this Warrant, and (c) shall, so long as the Warrant is outstanding, take all action necessary to reserve and keep available out of its authorized and unissued shares of Common Stock, solely for the purpose of effecting the
            exercise of the Warrant, the maximum number of shares of Common Stock as shall from time to time be necessary to effect the exercise of the Warrant then outstanding (without regard to any limitations on exercise).

        5. WARRANT HOLDER NOT DEEMED A STOCKHOLDER. Except as otherwise specifically provided herein, the Holder, solely in its capacity as a holder of this Warrant, shall not be entitled to vote or receive dividends or be
            deemed the holder of share capital of the Company for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in its capacity as the Holder of this Warrant, any of the rights of a stockholder of
            the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings, receive
            dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which it is then entitled to receive upon the due exercise of this Warrant.  In addition, nothing contained in this Warrant shall be
            construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company.
            Notwithstanding this Section 5, the Company shall provide the Holder with copies of the same notices and other information given to the stockholders of the Company generally, contemporaneously with the giving thereof to the stockholders.

        

        

        
          4

          
            

        

        

        

        6. REISSUANCE OF
              WARRANTS.

        

        (a) Transfer of Warrant. If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company, whereupon the Company will forthwith issue and deliver upon the order of the Holder a new
            Warrant (in accordance with Section 6(d)), registered as the Holder may request, representing the right to purchase the number of Warrant Shares being transferred by the Holder and, if less than the total number of Warrant Shares then
            underlying this Warrant is being transferred, a new Warrant (in accordance with Section 6(d)) to the Holder representing the right to purchase the number of Warrant Shares not being transferred.

         

          

        (b) Lost, Stolen or Mutilated Warrant. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant (as to which a written
            certification and the indemnification contemplated below shall suffice as such evidence), and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder to the Company in customary and reasonable form and, in
            the case of mutilation, upon surrender and cancellation of this Warrant, the Company shall execute and deliver to the Holder a new Warrant (in accordance with Section 6(d)) representing the right to purchase the Warrant Shares then underlying
            this Warrant.

         

          

        (c) Exchangeable for Multiple Warrants. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office of the Company, for a new Warrant or Warrants (in accordance with Section
            6(d)) representing in the aggregate the right to purchase the number of Warrant Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion of such Warrant Shares as is designated by the
            Holder at the time of such surrender; provided, however, no warrants for fractional shares of Common Stock shall be given.

        

        (d) Issuance of New Warrants. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant (i) shall be of like tenor with this Warrant, (ii) shall represent,
            as indicated on the face of such new Warrant, the right to purchase the Warrant Shares then underlying this Warrant (or in the case of a new Warrant being issued pursuant to Section 6(a) or Section 6(c), the Warrant Shares designated by the
            Holder which, when added to the number of shares of Common Stock underlying the other new Warrants issued in connection with such issuance, does not exceed the number of Warrant Shares then underlying this Warrant), (iii) shall have an issuance
            date, as indicated on the face of such new Warrant which is the same as the Issuance Date, and (iv) shall have the same rights and conditions as this Warrant.

        

        

        7. NOTICES; PAYMENTS.

        

        
          	
                  (a)

                	
                  The Company will give written notice to the Holder (i) immediately upon each adjustment of the Exercise Price and the number of Warrant
                    Shares, setting forth in reasonable detail, and certifying, the calculation of such adjustment(s) and (ii) at least fifteen (15) days prior to the date on which the Company closes its books or takes a record (A) with respect to any
                    dividend or distribution upon the shares of Common Stock  Any notices or communications required or permitted to be given by this Warrant must be (i) given in writing and (ii) personally delivered or mailed, by prepaid,
                    certified mail or overnight courier, or transmitted by electronic mail transmission (including PDF), to the party to whom such notice or communication is directed, to the mailing address or regularly-monitored electronic mail address of
                    such party as follows:

                

        

        

        

        
          5

          
            

        

        

        

        If to the Holder, then to:

         

        Boustead Securities, LLC

        6 Venture, Suite 395

        Irvine, CA 92618

        Attn: Keith Moore

        Email: keith@boustead1828.com

        

        

        If to the Company:

        

        

        Flora Growth Corp.

        65 Queen Street, Suite 900

        Toronto, Ontario M5H 2M5

        Attn: Luis Merchan, CEO

        Email: Luis.Merchan@floragrowth.ca

        

        

        

        
          	
                  (b)

                	
                  Payments. Whenever any payment is to be made by
                      the Company to any Person pursuant to this Warrant, such payment shall be made in lawful money of the United States of America via wire transfer of U.S. Dollars in immediately available funds in accordance with the Holder’s wire
                      transfer instructions delivered to the Company on or prior to such payment date or, in the absence of such instructions, by a certified check drawn on the account of the Company and sent via overnight courier service to such Person at
                      such address as previously provided to the Company in writing.

                

        

        

        

        8. AMENDMENT AND WAIVER.  Except as otherwise provided herein, the provisions of this Warrant may be amended and the Company may take any action herein prohibited, or omit to perform any act herein required to be
            performed by it, only if the Company has obtained the written consent of the Holder. No waiver shall be effective unless it is in writing and signed by an authorized representative of the waiving party.

        

        

        9SEVERABILITY.  If any provision of this Warrant is prohibited by law or otherwise
            determined to be invalid or unenforceable by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest extent that it would be valid and
            enforceable, and the invalidity or unenforceability of such provision shall not affect the validity of the remaining provisions of this Warrant so long as this Warrant as so modified continues to express, without material change, the original
            intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the
            parties or the practical realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid
            provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).

        

        

        
          6

          
            

        

        

        

        10. GOVERNING LAW. This Warrant shall be governed by and construed and enforced in accordance with, and all questions concerning the construction, validity, interpretation and performance of this Warrant shall be
            governed by, the internal laws of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application of the laws
            of any jurisdiction other than the State of New York. The Company hereby irrevocably submits to the exclusive jurisdiction of the federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute
            hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the
            jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Nothing contained herein shall be deemed to limit in any way any right to
            serve process in any manner permitted by law. Nothing contained herein shall be deemed or operate to preclude the Holder from bringing suit or taking other legal action against the Company in any other jurisdiction to collect on the Company’s
            obligations to the Holder or to enforce a judgment or other court ruling in favor of the Holder. If service of process is effected pursuant to the above sentence, such service will be deemed sufficient under New York law and the Company shall
            not assert otherwise. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. THE COMPANY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND
              AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS WARRANT OR ANY TRANSACTION CONTEMPLATED HEREBY.

        

        

        11. Reserved.

        

        

        12. CONSTRUCTION; HEADINGS. This Warrant shall be deemed to be jointly drafted by the Company and the Holder and shall not be construed against any Person as the drafter hereof.  The headings of this Warrant are for
            convenience of reference and shall not form part of, or affect the interpretation of, this Warrant. Terms used in this Warrant but defined in the other Transaction Documents shall have the meanings ascribed to such terms on the Closing Date in
            such other Transaction Documents unless otherwise consented to in writing by the Holder.

        

        

        13. DISPUTE RESOLUTION. In the case of a dispute as to the determination of the Exercise Price or FMV or the arithmetic calculation of the Warrant Shares (as the case may be), the Company or the Holder (as the case may
            be) shall submit the disputed determinations or arithmetic calculations (as the case may be) via electronic mail (a) within two (2) Business Days after receipt of the applicable notice giving rise to such dispute to the Company or the Holder
            (as the case may be) or (b) if no notice gave rise to such dispute, at any time after the Holder learned of the circumstances giving rise to such dispute (including, without limitation, as to whether any issuance or sale or deemed issuance or
            sale was an issuance or sale or deemed issuance or sale of Excluded Securities). If the Holder and the Company are unable to agree upon such determination or calculation (as the case may be) of the Exercise Price, or FMV or the number of
            Warrant Shares (as the case may be) within three (3) Business Days of such disputed determination or arithmetic calculation being submitted to the Company or the Holder (as the case may be), then the Company shall, within two (2) Business Days
            submit via electronic mail (i) the disputed determination of the Exercise Price or FMV (as the case may be) to an independent, reputable investment bank selected by the Holder or (ii) the disputed arithmetic calculation of the Warrant Shares to
            the Company’s independent, outside accountant. The Company shall cause at its expense the investment bank or the accountant (as the case may be) to perform the determinations or calculations (as the case may be) and notify the Company and the
            Holder of the results no later than ten (10) Business Days from the time it receives such disputed determinations or calculations (as the case may be). Such investment bank’s or accountant’s determination or calculation (as the case may be)
            shall be binding upon all parties absent demonstrable error.

        

        

        
          7

          
            

        

        

        

        14. EMEDIES, CHARACTERIZATION, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF. The remedies provided in this Warrant shall be cumulative and in addition to all other remedies available under this Warrant and the other
            Transaction Documents, at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit the right of the Holder to pursue actual damages for any failure by the Company to comply
            with the terms of this Warrant. The Company covenants to the Holder that there shall be no characterization concerning this instrument other than as expressly provided herein. Amounts set forth or provided for herein with respect to payments,
            exercises and the like (and the computation thereof) shall be the amounts to be received by the Holder and shall not, except as expressly provided herein, be subject to any other obligation of the Company (or the performance thereof). The
            Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach
            or threatened breach, the holder of this Warrant shall be entitled, in addition to all other available remedies, to an injunction restraining any breach, without the necessity of showing economic loss and without any bond or other security
            being required. The Company shall provide all information and documentation to the Holder that is requested by the Holder to enable the Holder to confirm the Company’s compliance with the terms and conditions of this Warrant (including, without
            limitation, compliance with Section 2 hereof). The issuance of shares and certificates for shares as contemplated hereby upon the exercise of this Warrant shall be made without charge to the Holder or such shares for any issuance tax or other
            costs in respect thereof, provided that the Company shall not be required to pay any tax which may be payable in respect of any transfer involved in the issuance and delivery of any certificate in a name other than the Holder or its agent on
            its behalf.

        

        15. TRANSFER.
            This Warrant may be offered for sale, sold, transferred or assigned without the consent of the Company.

        
          

          

          16. CERTAIN DEFINITIONS. 
            For purposes of this Warrant, the following terms shall have the following meanings:

        

        
          	
                  (a)

                	
                  Reserved.

                

        

        

        

        
          8

          
            

        

        

        

        
          	
                  (b)

                	
                  Bloomberg” means Bloomberg, L.P.

                

        

        

        
          	
                  (c)

                	
                  “Business Day” means any day other than Saturday, Sunday or other day on which commercial banks in
                    The City of New York are authorized or required by law to remain closed.

                

        

        

        
          	
                  (d)

                	
                  “Closing Sale Price” means, for any security as of any date, the last closing trade price for such
                    security on the Eligible Market, as reported by Bloomberg, or, if the Eligible Market begins to operate on an extended hours basis and does not designate the closing trade price, then the last trade price of such security prior to 4:00
                    p.m., New York time, as reported by Bloomberg, or, if the Eligible Market is not the principal securities exchange or trading market for such security, the last trade price of such security on the principal securities exchange or
                    trading market where such security is listed or traded as reported by Bloomberg, or if the foregoing does not apply, the last trade price of such security in the over-the-counter market on the electronic bulletin board for such security
                    as reported by Bloomberg, or, if no last trade price is reported for such security by Bloomberg, the average of the ask prices of any market makers for such security as reported in the “pink sheets” by Pink Sheets LLC (formerly the
                    National Quotation Bureau, Inc.). If the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Sale Price of such security on such date shall be the fair market value as
                    mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security, then such dispute shall be resolved in accordance with the procedures in Section 14. All
                    such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction during such period.

                

        

        

        
          	
                  (e)

                	
                   “Eligible Market” means The New York Stock Exchange, the NYSE American, the Nasdaq Global Select
                    Market, the Nasdaq Global Market or the Nasdaq Capital Market.

                

        

        

        
          	
                  (f)

                	
                     “Expiration Date” means the date that is five years from the Issuance Date, or, if such date falls
                    on a day other than a Business Day or on which trading does not take place on the Eligible Market (a “Holiday”), the next date that is not a Holiday.

                

        

        

        
          	
                  (g)

                	
                    “Parent Entity” of a Person means an entity that, directly or indirectly, controls the applicable
                    Person and whose Common Stock or equivalent equity security is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent Entity, the Person or Parent Entity with the largest public market capitalization
                    as of the date of consummation of the Fundamental Transaction.

                

        

        

        
          	
                  (h)

                	
                  “Person” means an individual, a limited liability company, a partnership, a joint venture, a
                    corporation, a trust, an unincorporated organization, any other entity or a government or any department or agency thereof.

                

        

        

        
          	
                  (i)

                	
                  “SEC” means the United States Securities and Exchange Commission.

                

        

        

        
          	
                  (j)

                	
                  “Successor Entity” means the Person (or, if so elected by the Holder, the Parent Entity) formed by,
                    resulting from or surviving any Fundamental Transaction or the Person (or, if so elected by the Holder, the Parent Entity) with which such Fundamental Transaction shall have been entered into.

                

        

        

        

        
          9

          
            

        

        

        

        
          	
                  (k)

                	
                  Trading Day” means any day on which
                      the Common Stock is traded on the Eligible Market, or, if the Eligible Market is not the principal trading market for the Common Stock, then on the principal securities exchange or securities market on which the Common Stock is then
                      traded, provided that “Trading Day” shall not include any day on which the Common Stock is scheduled to trade on such exchange or market for less than 4.5 hours or any day that the Common Stock is suspended from trading during the
                      final hour of trading on such exchange or market (or if such exchange or market does not designate in advance the closing time of trading on such exchange or market, then during the hour ending at 4:00 p.m., New York time) unless such
                      day is otherwise designated as a Trading Day in writing by the Holder.

                

        

        

        
          	
                  (l)

                	
                  “Voting Stock” of a Person means capital stock of such Person of the class or classes pursuant to
                    which the holders thereof have the general voting power to elect, or the general power to appoint, at least a majority of the board of directors, managers or trustees of such Person (irrespective of whether or not at the time capital
                    stock of any other class or classes shall have or might have voting power by reason of the happening of any contingency).

                

        

        

        
          	
                  (m)

                	
                  “FMV” means, for any date, the price determined by the first of the following clauses that applies:
                    (a) if the Common Stock is then listed or quoted on a Eligible Market, the value shall be deemed to be the highest intra-day or closing price on any trading day on such Eligible Market on which the Common Stock is then listed or quoted
                    as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)) during the five trading days preceding the exercise, (b)  if OTCQB or OTCQX is not an Eligible Market, the
                    value shall be deemed to be the highest intra-day or closing price on any trading day on the OTCQB or OTCQX on which the Common Stock is then quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City
                    time) to 4:02 p.m. (New York City time)) during the five trading days preceding the exercise, as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then
                    reported in the “Pink Sheets” published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the “OTC Markets Group”, the value shall be deemed to be the highest intra-day or
                    closing price on any trading day on the Pink Sheets on which the Common Stock is then quoted as reported by OTC Markets Group (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)) during the five
                    trading days preceding the exercise, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company.

                

        

        

        

        [signature page follows]

        
          10

          
            

        

        

        

        IN WITNESS WHEREOF, the Company has caused
            this Warrant to Purchase Common Stock to be duly executed as of the Issuance Date set out above.

        	
                 

                 

                Flora Growth Corp.

                 

              	 
	 	 	 	 
	 	 	 
	By: /s/ Luis Merchan 

              	 
	
                Name: Luis Merchan

              	 
	
                Title: CEO

              	 
	 	 

        

        

        

        

        

        

        

        

        

        

        

        

        

        

        

        

        
          11

          
            

        

        EXHIBIT A

        

        

        EXERCISE NOTICE

        TO BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS

        WARRANT TO PURCHASE COMMON STOCK

        

        

        FLORA GROWTH CORP.

        

        

        The undersigned holder hereby exercises the right to purchase _________________ Common Stock (“Warrant Shares”)
          of Flora Growth Corp., a corporation incorporated in the Province of Ontario (the “Company”), evidenced by Warrant to Purchase Common Stock No. _______  (the “Warrant”). Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in the Warrant.

        

        

        1. Form of Exercise Price.  The Holder intends that payment of the Exercise Price shall be made as:

        

        

        	

              	____________	
                a “Cash Exercise” with respect to _________________ Warrant Shares; and/or

              

        

        

        	

              	____________	
                a “Cashless Exercise” with respect to _______________ Warrant Shares.

              

        

        

        In the event that the Holder has elected a Cashless Exercise with respect to some or all of the Warrant Shares to be issued pursuant hereto, the Holder
          hereby represents and warrants that (i) this Exercise Notice was executed by the Holder on the date set forth below and (ii) if applicable, the FMV as of the date prior to the date of the Exercise Notice was $________.

        

        

        1. Form of Exercise Price.  The Holder intends that payment of the Exercise Price shall be made as a “Cash Exercise”.

        

        

        2. Payment of Exercise Price. In the event that the Holder has elected a Cash Exercise with respect to some or all of the Warrant Shares to be issued pursuant hereto, the Holder shall pay the Aggregate
            Exercise Price in the sum of $___________________ to the Company in accordance with the terms of the Warrant.

        

        

        3. Delivery of Warrant Shares.  The Company shall deliver to Holder, or its designee or agent as specified below, __________ Warrant
          Shares in accordance with the terms of the Warrant.  Delivery shall be made to Holder, or for its benefit, as follows:

        

        

        ☐ Check here if requesting delivery as
            a certificate to the following name and to the following address:

        	
                 

                 

                Issue to:

              	 
	 	 
	 	 

        

        

        

        

        
          12

          
            

        

        

        

        	☐	
                Check here if requesting delivery by Deposit/Withdrawal at Custodian as follows:

              

        	
                 

                DTC Participant:

              	 
	
                 

                DTC Number:

              	 
	
                 

                Account Number:

              	 
	 	 

        

        

        	
                Date: _____________ __, 

                 

                

                  Name of Registered Holder

                 

              
	
                By: 

                    Name:

                    Title:

                   

                 

                Tax ID:_____________________

                 

                Electronic Mail:_______________________

              

        
          13

          
            

        

        EXHIBIT B

        

        

        ACKNOWLEDGMENT

        

        

        The Company hereby acknowledges this Exercise Notice and hereby directs ______________ to issue the above indicated number of shares of Common Stock in
          accordance with the Transfer Agent Instructions dated _________, 20__, from the Company and acknowledged and agreed to by _______________.

        

        

        Flora Growth Corp.

        

        

                                                                    By:____________________________________

        Name:

        Title:

        

        

        

        

        

        

        

        

        

        

         

        

         

        

         

        

      

    

  

  14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00336-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00336-of-00352.parquet"}]]